The salient point I have bolded....
2. Yes, the board reviews its cash position along with its expenditure commitments and funding requirements on an ongoing basis. PKO intends to conduct a pro-rata rights issue to fund ongoing operations later this quarter. The board believes that PKO has the ability to successfully raised additional capital, based on its previous ability to raise funds when required and the ongoing support of PKO’s shareholders.
- Forums
- ASX - By Stock
- PKO
- Ann: Response to ASX Appendix 5B query
Ann: Response to ASX Appendix 5B query, page-2
Featured News
Add PKO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.635M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500000 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2500000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 8663282 | 0.003 |
4 | 6244001 | 0.002 |
3 | 7833239 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 500000 | 1 |
0.005 | 3067552 | 2 |
0.006 | 339044 | 3 |
0.007 | 215697 | 3 |
0.008 | 218888 | 3 |
Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
Featured News
PKO (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online